Results 141 to 150 of about 320,703 (320)

Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24–72 Weeks [PDF]

, 2011
Christoph Sarrazin, Susanne Schwendy, Bernd Möller, Nektarios Dikopoulos, Peter Buggisch, Jens Encke, G Teuber, Tobias Goeser, Robert Thimme, Hartwig Klinker, Wulf O. Boecher, Ewert Schulte‐Frohlinde, R Prinzing, Eva Herrmann, Stefan Zeuzem, Thomas Berg   +15 more
openalex   +1 more source

Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust Study [PDF]

, 2010
Background and study aims : Large international clinical trials conducted in the past 5 years rapidly improved the treatment of chronic hepatitis C; however, it is unclear whether the advances seen in clinical trials are being paralleled by similar ...
Adler, M, Bastens, B, Brasseur, JP, Colle, Isabelle, Delwaide, J, Denys, AM, Golstein, P, Henrion, J, Horsmans, Y, Michielsen, P, Mulkays, JP, Nevens, F, Van Steenbergen, W, Van Vlierberghe, Hans, Yap, P   +14 more
core   +2 more sources

Interferons in the treatment of myeloproliferative neoplasms

Therapeutic Advances in Hematology
Interferons are cytokines with immunomodulatory properties and disease-modifying effects that have been used to treat myeloproliferative neoplasms (MPNs) for more than 35 years.
Pankit Vachhani, John Mascarenhas, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M. Palmer, Aaron T. Gerds, Lucia Masarova, Andrew T. Kuykendall, Raajit K. Rampal, Ruben Mesa, Srdan Verstovsek   +11 more
doaj   +1 more source

Psychosis during peginterferon-alpha2a and ribavirin therapy: case report

Brazilian Journal of Infectious Diseases
Pegylated Interferon-alpha, combined with ribavirin, gives high sustained virological response in patients with hepatitis C virus, an important public health problem and one of the most frequent chronic infectious diseases worldwide.
Lucas C. Quarantini, Simone Cunha Cruz, Susana Carolina Batista-Neves, Raymundo Paraná, Ângela Miranda-Scippa, Rodrigo A. Bressan   +5 more
doaj   +1 more source

Treatment of chronic hepatitis C in patients unresponsive to interferon. Interest of re-treatment combining interferon induction therapy and ribavirin (a multicenter pilot study) [PDF]

, 2005
Aim About 45% of patients with chronic hepatitis C are unresponsive to the present reference treatment combining pegelated interferon plus ribavirin; before pegylated interferon was available the non-response rate was around 60%.
A. Abergel, B. Giraudeau, C. Silvain, D. Labarriere, Fontevraud Study Group, J. Gros, P. Veillon, S.N. Si Ahmed, V. Loustaud-Ratti, X. Causse, Y. Bacq   +10 more
core   +1 more source

Systematic review: treatment of chronic hepatitis B virus infection by pegylated interferon [PDF]

, 2005
Alex Hui, Henry Lik‐Yuen Chan, A. Y.‐K. CHEUNG, Graham Cooksley, Joseph J.�Y. Sung   +4 more
openalex   +1 more source

Effect of Interferon and Ribavirin on hepatitis C virus [PDF]

, 2011
Hepatitis C Virus (HCV) is a blood-borne infection that can lead to many liver diseases and hence leads to its failure [1]. The current treatment for HCV infection involves combination therapy of pegylated Interferon and Ribavirin [2].
Tudu, Saraswati
core  

Digital ischemic necrosis caused by pegylated interferon in a patient with hepatitis C

, 2011
Jana G. Hashash
openalex   +2 more sources

Efficacy of Pegylated Interferon Plus Ribavirin in Treatment of Chronic Hepatitis C Patients in India in ‘Real-Life’ Setting [PDF]

, 2014
Omesh Goyal, Ajit Sood, Vandana Midha, Syed Hissar   +3 more
openalex   +1 more source

ARE ELDERLY PATIENTS POOR CANDIDATES FOR PEGYLATED INTERFERON PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C? [PDF]

, 2006
Annarosa Floreani, E. Minola, I. Carderi, Francesco Ferrara, E. Rosa Rizzotto, Vincenzo Baldo   +5 more
openalex   +1 more source